Patent Expiry

Patent/Exclusivity Expiry: IDVYNSO

Other upcoming events for NSRX

Phase 3 ReadoutPhase 3 Topline: Efficacy and Safety of FMXIN002 Epinephrine Powder Nasal Spray for the Treatment of Acute Allergic R
Patent ExpiryPatent/Exclusivity Expiry: FOUNDAYO

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Patent/Exclusivity Expiry: IDVYNSO — NSRX Patent Expiry | BioSniper